According to the latest data from the Chinese Center for Disease Control and Prevention, the influenza virus positivity rate continues to rise, of which more than % are influenza A. As the number of influenza infections increases, the sales of antiinfluenza drugs have continued to grow recently. The new generation of "magic influenza drug" Mabaloxavir is even priced as high as yuan in some pharmacies.
The traditional Chinese medicine sector also rebounded strongly from the continuous decline in the past few days, rising .% today. Yiling Pharmaceutical, Zhongsheng Pharmaceutical, Taiji Group and others rose sharply. Recently, the lebanon phone number list results of the third batch of national centralized procurement of traditional Chinese medicines were announced, involving manufacturers among the varieties of medicines. This centralized procurement has added three times the "fuse line", which is expected to effectively squeeze out the inflated prices.
Another catalyst for the pharmaceutical sector comes from weight loss drugs. According to the agency, the global market size of weight loss drugs will exceed US billion in the long term, and there is ample room for growth. Recently, a semaglutide chewable candy developed by Eden was launched on the market. It can conveniently provide the benefits of semaglutide and other GLP drugs without needle injection, realizing personalized medication.